{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:14:22Z","timestamp":1791357262146,"version":"4.3.1"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004733","name":"Universidade de Macau","doi-asserted-by":"publisher","award":["MYRG2015-00230-FHS"],"award-info":[{"award-number":["MYRG2015-00230-FHS"]}],"id":[{"id":"10.13039\/501100004733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004733","name":"Universidade de Macau","doi-asserted-by":"publisher","award":["MYRG2016-00005-FHS"],"award-info":[{"award-number":["MYRG2016-00005-FHS"]}],"id":[{"id":"10.13039\/501100004733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009331","name":"Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support","doi-asserted-by":"publisher","award":["ZYLX201607"],"award-info":[{"award-number":["ZYLX201607"]}],"id":[{"id":"10.13039\/501100009331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2016YFC1307200"],"award-info":[{"award-number":["2016YFC1307200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014730","name":"Taipei City Government","doi-asserted-by":"publisher","award":["10501-62-012"],"award-info":[{"award-number":["10501-62-012"]}],"id":[{"id":"10.13039\/501100014730","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.ajp.2019.08.010","type":"journal-article","created":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T11:36:22Z","timestamp":1566819382000},"page":"74-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"special_numbering":"C","title":["Prescription of antipsychotic and concomitant medications for adult Asian schizophrenia patients: Findings of the 2016 Research on Asian Psychotropic Prescription Patterns (REAP) survey"],"prefix":"10.1016","volume":"45","author":[{"given":"Min","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-Nan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinge","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Yu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunice","family":"Najoan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy Abraham","family":"Kallivayalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kittisak","family":"Viboonma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruzita","family":"Jamaluddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afzal","family":"Javed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duong Thi Quynh","family":"Hoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Iida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiha","family":"Swe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Ling","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongchon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helal Uddin","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"De Alwis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen F.K.","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman","family":"Sartorius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chay-Hoon","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mian-Yoon","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naotaka","family":"Shinfuku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Ku","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajit","family":"Avasthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Grover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee H.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabor S.","family":"Ungvari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Tao","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajp.2019.08.010_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/j.1440-1614.2005.01516.x","article-title":"Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders","volume":"39","year":"2005","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.ajp.2019.08.010_bib0010","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"APA","year":"1994"},{"key":"10.1016\/j.ajp.2019.08.010_bib0015","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1093\/schbul\/sbn030","article-title":"Does the addition of a second antipsychotic drug improve clozapine treatment?","volume":"35","author":"Barbui","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.ajp.2019.08.010_bib0020","first-page":"127","article-title":"Hospitalization and cost after switching from atypical to typical antipsychotics in schizophrenia patients in Thailand","volume":"8","author":"Boonlue","year":"2016","journal-title":"ClinicoEconomics and outcomes research: CEOR"},{"key":"10.1016\/j.ajp.2019.08.010_bib0025","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00228-003-0719-7","article-title":"Comparisons of psychotropic drug prescribing patterns in acute psychiatric wards across Europe","volume":"60","author":"Bowers","year":"2004","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ajp.2019.08.010_bib0030","doi-asserted-by":"crossref","first-page":"A1","DOI":"10.1016\/j.ajp.2018.04.024","article-title":"Antipsychotic Polypharmacy: state of the science and guidelines for practice. it\u2019s difficult to stop once you start","volume":"33","author":"Bruijnzeel","year":"2018","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.ajp.2019.08.010_bib0035","first-page":"7S","article-title":"Clinical practice guidelines treatment of schizophrenia","volume":"50","author":"Canadian Psychiatric Association","year":"2005","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.ajp.2019.08.010_bib0040","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1046\/j.1440-1614.2002.01037.x","article-title":"Antipsychotic use in Australia: the patients\u2019 perspective","volume":"36","author":"Castle","year":"2002","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.ajp.2019.08.010_bib0045","first-page":"518","article-title":"Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials","volume":"158","author":"Chakos","year":"2004","journal-title":"Focus"},{"key":"10.1016\/j.ajp.2019.08.010_bib0050","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1176\/ps.2006.57.8.1094","article-title":"Baseline use of concomitant psychotropic medications to treat schizophrenia in the CATIE trial","volume":"57","author":"Chakos","year":"2006","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.ajp.2019.08.010_bib0055","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/schbul\/sby058","article-title":"Global epidemiology and burden of schizophrenia: findings from the global burden of disease study 2016","volume":"44","author":"Charlson","year":"2018","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.ajp.2019.08.010_bib0060","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1440-1819.2004.01194.x","article-title":"Antipsychotic drug prescription for schizophrenia in East Asia: rationale for change","volume":"58","author":"Chong","year":"2004","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.ajp.2019.08.010_bib0065","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1758-5872.2010.00068.x","article-title":"Prescribing antipsychotic drugs for inpatients with schizophrenia in Asia: comparison of REAP\u20102001 and REAP\u20102004 studies","volume":"2","author":"Chong","year":"2010","journal-title":"Asia-pacific Psychiatry"},{"key":"10.1016\/j.ajp.2019.08.010_bib0070","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3928\/0048-5713-19971001-11","article-title":"Psychopharmacology of violence: part II: beyond the acute episode","volume":"27","author":"Citrome","year":"1997","journal-title":"Psychiatr. Ann."},{"key":"10.1016\/j.ajp.2019.08.010_bib0075","first-page":"853","article-title":"The burden of depressive symptoms in people with schizophrenia","volume":"32","author":"Conley","year":"2009","journal-title":"Psychiatric Clin."},{"key":"10.1016\/j.ajp.2019.08.010_bib0080","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/schbul\/sbn018","article-title":"Antipsychotic combinations vs monotherapy in schizophrenia: a meta-analysis of randomized controlled trials","volume":"35","author":"Correll","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.ajp.2019.08.010_bib0085","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.schres.2011.02.016","article-title":"Antipsychotic polypharmacy: a survey study of prescriber attitudes, knowledge and behavior","volume":"131","author":"Correll","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ajp.2019.08.010_bib0090","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/emermed-2017-206944","article-title":"Effects of prophylactic anticholinergic medications to decrease extrapyramidal side effects in patients taking acute antiemetic drugs: a systematic review and meta-analysis","volume":"35","author":"D\u2019Souza","year":"2018","journal-title":"EMJ"},{"key":"10.1016\/j.ajp.2019.08.010_bib0095","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/2042098618756261","article-title":"Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine","volume":"9","author":"De Berardis","year":"2018","journal-title":"Ther. Adv. Drug Saf."},{"key":"10.1016\/j.ajp.2019.08.010_bib0100","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.psychres.2006.07.012","article-title":"Anticholinergic use in hospitalised schizophrenic patients in Belgium","volume":"152","author":"De Hert","year":"2007","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.ajp.2019.08.010_bib0105","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1177\/0269881108100777","article-title":"Cognitive effects of antipsychotic dosage and polypharmacy: a study with the BACS in patients with schizophrenia and schizoaffective disorder","volume":"24","author":"Elie","year":"2010","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ajp.2019.08.010_bib0110","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1176\/appi.ajp.2011.10060908","article-title":"Effectiveness of switching from antipsychotic polypharmacy to monotherapy","volume":"168","author":"Essock","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2019.08.010_bib0115","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/15622970510030090","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia","volume":"6","author":"Falkai","year":"2005","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.ajp.2019.08.010_bib0120","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1177\/106002809703101114","article-title":"Ethnicity and antipsychotic response","volume":"31","author":"Frackiewicz","year":"1997","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ajp.2019.08.010_bib0125","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.schres.2012.03.018","article-title":"Prevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009","volume":"138","author":"Gallego","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ajp.2019.08.010_bib0130","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1517\/14740338.2012.683523","article-title":"Safety and tolerability of antipsychotic polypharmacy","volume":"11","author":"Gallego","year":"2012","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.ajp.2019.08.010_bib0135","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/0004867416641195","article-title":"Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders","volume":"50","author":"Galletly","year":"2016","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.ajp.2019.08.010_bib0140","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/acps.12854","article-title":"Efficacy and safety of antidepressant augmentation of continued antipsychotic treatment in patients with schizophrenia","volume":"137","author":"Galling","year":"2018","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.ajp.2019.08.010_bib0145","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1176\/appi.ajp.2009.09060802","article-title":"International consensus study of antipsychotic dosing","volume":"167","author":"Gardner","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2019.08.010_bib0150","first-page":"205","article-title":"What can we do about acute extrapyramidal symptoms? J. Psychiatr","volume":"7","author":"Gray","year":"2000","journal-title":"Ment. Health Nurs."},{"key":"10.1016\/j.ajp.2019.08.010_bib0155","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2165\/00023210-200620040-00003","article-title":"The SOHO (Schizophrenia outpatient health outcome) study","volume":"20","author":"Haro","year":"2006","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ajp.2019.08.010_bib0160","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1192\/pb.26.11.414","article-title":"The results of a multi-centre audit of the prescribing of antipsychotic drugs for in-patients in the UK","volume":"26","author":"Harrington","year":"2002","journal-title":"Psychiatr. Bull."},{"key":"10.1016\/j.ajp.2019.08.010_bib0165","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3109\/15622975.2012.696143","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance","volume":"13","author":"Hasan","year":"2012","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.ajp.2019.08.010_bib0170","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ajp.2019.02.005","article-title":"Real-world effectiveness of antipsychotic monotherapy and polytherapy in 1543 patients with acute-phase schizophrenia","volume":"40","author":"Hatta","year":"2019","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.ajp.2019.08.010_bib0175","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1176\/appi.ajp.2016.15081035","article-title":"Efficacy and safety of antidepressants added to antipsychotics for schizophrenia: a systematic review and meta-analysis","volume":"173","author":"Helfer","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2019.08.010_bib0180","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.schres.2012.01.008","article-title":"Antidepressant prescribing patterns among VA patients with schizophrenia","volume":"136","author":"Himelhoch","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ajp.2019.08.010_bib0185","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ajp.2015.01.001","article-title":"Course and outcome of schizophrenia in Asian countries: review of research in the past three decades","volume":"14","author":"Holla","year":"2015","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.ajp.2019.08.010_bib0190","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1017\/S0033291715002159","article-title":"Single i.v. Ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study","volume":"46","author":"Hu","year":"2016","journal-title":"Psychol. Med. (Paris)"},{"key":"10.1016\/j.ajp.2019.08.010_bib0195","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ajp.2018.12.011","article-title":"A qualitative exploration of clozapine prescribing and monitoring practices in the Arabian Gulf countries","volume":"39","author":"Ismail","year":"2019","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.ajp.2019.08.010_bib0200","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.psychres.2013.03.014","article-title":"Antipsychotic polypharmacy: a Japanese survey of prescribers\u2019 attitudes and rationales","volume":"209","author":"Kishimoto","year":"2013","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.ajp.2019.08.010_bib0205","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-clinpsy-032813-153657","article-title":"Excess early mortality in schizophrenia","volume":"10","author":"Laursen","year":"2014","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"10.1016\/j.ajp.2019.08.010_bib0210","first-page":"161","article-title":"Practice guideline for the treatment of partients with schizophrenia","author":"Lehman","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2019.08.010_bib0215","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1600-0447.2007.01095.x","article-title":"Physical illness and schizophrenia: a review of the literature","volume":"116","author":"Leucht","year":"2007","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.ajp.2019.08.010_bib0220","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ajp.2019.08.010_bib0225","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","article-title":"Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis","volume":"373","author":"Leucht","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ajp.2019.08.010_bib0230","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/schbul\/sbv037","article-title":"Dose equivalents for second-generation antipsychotic drugs: the classical mean dose method","volume":"41","author":"Leucht","year":"2015","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.ajp.2019.08.010_bib0235","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1176\/ajp.140.4.490","article-title":"Neuroleptic dosage for asians","volume":"140","author":"Lin","year":"1983","journal-title":"A. J. Psychiatry"},{"key":"10.1016\/j.ajp.2019.08.010_bib0240","first-page":"289","article-title":"The comparison of use of antipsychotics in first-episode patients with schizophrenia (in Chinese)","volume":"15","author":"Liu","year":"2003","journal-title":"Med. J. Chin. People Health"},{"key":"10.1016\/j.ajp.2019.08.010_bib0245","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ajp.2018.03.012","article-title":"Prevalence and correlates of antipsychotic polypharmacy in Hong Kong","volume":"33","author":"Lung","year":"2018","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.ajp.2019.08.010_bib0250","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/archpsyc.60.1.82","article-title":"Clozapine treatment for suicidality in schizophrenia: international suicide prevention trial (InterSePT)","volume":"60","author":"Meltzer","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ajp.2019.08.010_bib0255","series-title":"Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care (update)","author":"National Collaborating Centre for Mental Health","year":"2009"},{"key":"10.1016\/j.ajp.2019.08.010_bib0260","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/1472-6963-10-257","article-title":"Mental health priorities in Vietnam: a mixed-methods analysis","volume":"10","author":"Niemi","year":"2010","journal-title":"BMC Health Serv. Res."},{"key":"10.1016\/j.ajp.2019.08.010_bib0265","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1080\/14740338.2016.1201475","article-title":"An update of safety of clinically used atypical antipsychotics","volume":"15","author":"Orsolini","year":"2016","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.ajp.2019.08.010_bib0270","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0278-5846(01)00279-2","article-title":"The use of concomitant medications in psychiatric inpatients treated with either olanzapine or other antipsychotic agents: a naturalistic study at a state psychiatric hospital","volume":"26","author":"Parepally","year":"2002","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ajp.2019.08.010_bib0275","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1176\/ajp.154.9.1228","article-title":"Economic reforms and the acute inpatient care of patients with schizophrenia: the Chinese experience","volume":"154","author":"Phillips","year":"1997","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2019.08.010_bib0280","doi-asserted-by":"crossref","first-page":"e3150","DOI":"10.1371\/journal.pone.0003150","article-title":"Pharmacotherapy of schizophrenic patients: preponderance of off-label drug use","volume":"3","author":"Pickar","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.ajp.2019.08.010_bib0285","series-title":"Revised Consensus Statement on High Dose Antipsychotic Medication (council Report CR138)","author":"Royal College of Psychiatrists","year":"2006"},{"key":"10.1016\/j.ajp.2019.08.010_bib0290","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.schres.2010.07.012","article-title":"Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis","volume":"123","author":"Rummel-Kluge","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ajp.2019.08.010_bib0295","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1001\/archpsyc.64.10.1123","article-title":"A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?","volume":"64","author":"Saha","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ajp.2019.08.010_bib0300","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/JCP.0000000000000790","article-title":"The impact of medication anticholinergic burden on cognitive performance in people with schizophrenia","volume":"37","author":"San Ang","year":"2017","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ajp.2019.08.010_bib0305","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1080\/09540260802397560","article-title":"Pharmacotherapy for schizophrenic inpatients in East Asia--changes and challenges","volume":"20","author":"Shinfuku","year":"2008","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.ajp.2019.08.010_bib0310","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1055\/s-2004-827174","article-title":"High dose antipsychotic use in schizophrenia: findings of the REAP (research on east Asia psychotropic prescriptions) study","volume":"37","author":"Sim","year":"2004","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.ajp.2019.08.010_bib0315","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/hup.571","article-title":"Depot antipsychotic use in schizophrenia: an East Asian perspective","volume":"19","author":"Sim","year":"2004","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"10.1016\/j.ajp.2019.08.010_bib0320","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1365-2125.2008.03304.x","article-title":"High-dose antipsychotic use in schizophrenia: a comparison between the 2001 and 2004 Research on East Asia Psychotropic Prescription (REAP) studies","volume":"67","author":"Sim","year":"2009","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ajp.2019.08.010_bib0325","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1017\/S1461145711000563","article-title":"Adjunctive mood stabilizer treatment for hospitalized schizophrenia patients: Asia psychotropic prescription study (2001\u20132008)","volume":"14","author":"Sim","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ajp.2019.08.010_bib0330","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.schres.2011.09.016","article-title":"Treatment resistant schizophrenia and response to antipsychotics: a review","volume":"133","author":"Suzuki","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ajp.2019.08.010_bib0335","first-page":"12","article-title":"Recommendations for the pharmacotherapy of mental disorders","volume":"58","author":"The Royal College of Psychiatrists of Thailand","year":"2013","journal-title":"J Psychiatr Assoc Thailand"},{"key":"10.1016\/j.ajp.2019.08.010_bib0340","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1192\/bjp.164.4.448","article-title":"The use of high-dose antipsychotic medication","volume":"164","author":"Thompson","year":"1994","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.ajp.2019.08.010_bib0345","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1001\/archgenpsychiatry.2011.1532","article-title":"Polypharmacy with antipsychotics, antidepressants, or benzodiazepines and mortality in schizophrenia","volume":"69","author":"Tiihonen","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ajp.2019.08.010_bib0350","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1017\/S146114571000163X","article-title":"Adjunctive benzodiazepine treatment of hospitalized schizophrenia patients in Asia from 2001 to 2008","volume":"14","author":"Tor","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ajp.2019.08.010_bib0355","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006391","article-title":"Benzodiazepines for schizophrenia","author":"Volz","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ajp.2019.08.010_bib0360","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"390","author":"Vos","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ajp.2019.08.010_bib0365","series-title":"Mental Health","author":"WHO","year":"2014"},{"key":"10.1016\/j.ajp.2019.08.010_bib0370","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4088\/JCP.v64n0607","article-title":"Chlorpromazine equivalent doses for the newer atypical antipsychotics","volume":"64","author":"Woods","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ajp.2019.08.010_bib0375","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1055\/s-2007-992143","article-title":"Clinical and social determinants of long-term use of benzodiazepines and its impact on quality of life of Chinese schizophrenia patients","volume":"40","author":"Xiang","year":"2007","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.ajp.2019.08.010_bib0380","doi-asserted-by":"crossref","first-page":"e66154","DOI":"10.1371\/journal.pone.0066154","article-title":"Use of clozapine in older Asian patients with schizophrenia between 2001 and 2009","volume":"8","author":"Xiang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ajp.2019.08.010_bib0385","first-page":"E81","article-title":"Adjunctive antidepressant prescriptions for hospitalized patients with schizophrenia in Asia (2001\u20132009)","volume":"5","author":"Xiang","year":"2013","journal-title":"Asia-Pacif. Psychiatry"},{"key":"10.1016\/j.ajp.2019.08.010_bib0390","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1017\/S1041610211002791","article-title":"Prescribing patterns of low doses of antipsychotic medications in older Asian patients with schizophrenia, 2001\u20132009","volume":"24","author":"Xiang","year":"2012","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.ajp.2019.08.010_bib0395","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1097\/JCP.0b013e3182726623","article-title":"Common use of antipsychotic polypharmacy in older Asian patients with schizophrenia (2001-2009)","volume":"32","author":"Xiang","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ajp.2019.08.010_bib0400","first-page":"2001","article-title":"Comparison of treatment patterns in schizophrenia between China and Japan","author":"Xiang","year":"2017","journal-title":"Asia-Pacif. Psychiatry"},{"key":"10.1016\/j.ajp.2019.08.010_bib0405","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1017\/S2045796015000694","article-title":"Trends in the access to and the use of antipsychotic medications and psychotropic co-treatments in Asian patients with schizophrenia","volume":"25","author":"Xiang","year":"2016","journal-title":"Epidemiol. Psychiatr. Sci."},{"key":"10.1016\/j.ajp.2019.08.010_bib0410","doi-asserted-by":"crossref","first-page":"968","DOI":"10.3109\/00048674.2011.607426","article-title":"Clozapine use in schizophrenia: findings of the Research on Asia Psychotropic Prescription (REAP) studies from 2001 to 2009","volume":"45","author":"Xiang","year":"2011","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.ajp.2019.08.010_bib0415","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1055\/s-0031-1275658","article-title":"Use of anticholinergic drugs in patients with schizophrenia in Asia from 2001 to 2009","volume":"44","author":"Xiang","year":"2011","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.ajp.2019.08.010_bib0420","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-0031-1286345","article-title":"Antipsychotic polypharmacy in inpatients with schizophrenia in Asia (2001-2009)","volume":"45","author":"Xiang","year":"2012","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.ajp.2019.08.010_bib0425","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/hup.821","article-title":"Clinical correlates of clozapine prescription for schizophrenia in China","volume":"22","author":"Xiang","year":"2007","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.ajp.2019.08.010_bib0430","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0165-1781(98)00114-0","article-title":"An investigation of ethnic and gender differences in the pharmacodynamics of haloperidol","volume":"81","author":"Zhang-Wong","year":"1998","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.ajp.2019.08.010_bib0435","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1017\/S1461145712001277","article-title":"Efficacy and safety of individual second-generation vs. First-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis","volume":"16","author":"Zhang","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201819305684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201819305684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:34:13Z","timestamp":1761755653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876201819305684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":87,"alternative-id":["S1876201819305684"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2019.08.010","relation":{},"ISSN":["1876-2018"],"issn-type":[{"value":"1876-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prescription of antipsychotic and concomitant medications for adult Asian schizophrenia patients: Findings of the 2016 Research on Asian Psychotropic Prescription Patterns (REAP) survey","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2019.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}